Ukugqithisa kweDimenhydrinate

I-Dimenhydrinate luhlobo lonyango olubizwa ngokuba yi-antihistamine.

I-Dimenhydrinate overdose yenzeka xa umntu ethatha ngaphezulu kwesiqhelo okanye isixa esinconyelwayo sonyango. Oku kunokuba ngengozi okanye ngenjongo.

Eli nqaku lelolwazi kuphela. SUKUYISETYENZISE ukunyanga okanye ukulawula ukugqithisa ngokwenyani. Ukuba wena okanye umntu onaye une-overdose, fowunela inombolo yongxamiseko yendawo yakho (enje nge-911), okanye iziko lakho lendawo yetyhefu linokufikelelwa ngokuthe ngqo ngokutsalela umnxeba wenombolo yasimahla yoNcedo lweTyhefu (1-800-222-1222) naphi na eUnited States.

I-Dimenhydrinate inokuba yingozi kwisixa esikhulu.

I-Dimenhydrinate ifumaneka kumayeza athile okwaliwa. Kukwamayeza amaninzi asetyenziselwa ukunyanga isicaphucaphu, ukugabha kunye nokugula okushukumayo.

• Isenokuba kumayeza anala magama ebhrendi:
• IDramamine
• Qhuba
• Wal-Dram
• IGaviscon isicaphucaphu
• Qinisekisa
• IGravol
• Marmine
• UNico-Vert
• I-Triptone

Apha ngezantsi kukho iimpawu ze-dimenhydrinate overdose kwiindawo ezahlukeneyo zomzimba.

I-bladder kunye neenyawo

• Ukungakwazi ukuchama

AMEHLO, IINDlebe, iimpumlo, UMLOMO NOMQOLO

• Umbono omfiliba
• Umlomo owomileyo
• Ukwandiswa kwabafundi
• Amehlo awomileyo kakhulu
• Iyakhala ezindlebeni

IINTLIZIYO ZENTLIZIYO NEGAZI

• Uxinzelelo lwegazi oluphantsi
• Ukubetha kwentliziyo okukhawulezayo

INKQUBO YENKONZO

• Ukuphazamiseka
• Ukudideka
• Ukuxhuzula
• Delirium
• Uxinzelelo
• Ukozela
• Imibono (ukubona okanye ukuva izinto ezingekhoyo)
• Ukwanda kobuthongo
• Uvalo
• Ukungcangcazela
• Ukungazinzi

ULusu

• Isikhumba esomileyo, esibomvu

ISisu kunye namathumbu

• Isicaphucaphu
• Ukuhlanza

Ngaba olu lwazi lukulungele:

• Ubudala bomntu, ubunzima, kunye nemeko
• Igama lemveliso (izithako kunye namandla, ukuba kuyaziwa)
• Ixesha laliginyiwe
• Isixa siginyiwe
• Ukuba amayeza amiselwe umntu lowo

Iziko lakho lokulawula ityhefu lingafikelelwa ngokuthe ngqo ngokutsalela umnxeba wenombolo yasimahla yasimahla kuTyhefu (1-800-222-1222) naphi na e-United States. Inombolo yomnxeba kazwelonke iya kukuvumela ukuba uthethe neengcali kwiityhefu. Baza kukunika eminye imiyalelo.

Le yinkonzo yasimahla neyimfihlo. Onke amaziko olawulo lwetyhefu aseMelika asebenzisa le nombolo yesizwe. Kuya kufuneka ubize ukuba unemibuzo malunga netyhefu okanye ukuthintela ityhefu. AKUFUNI ukuba ibe yingxakeko. Ungatsalela umnxeba nangasiphi na isizathu, iiyure ezingama-24 ngosuku, iintsuku ezisi-7 ngeveki.

Thatha ikhonteyina leyo uyise esibhedlele, ukuba kunokwenzeka.

Umboneleli wezempilo uya kulinganisa kwaye abeke esweni iimpawu ezibalulekileyo zomntu, kubandakanya iqondo lobushushu, ukubetha kwentliziyo, inqanaba lokuphefumla, kunye noxinzelelo lwegazi.

Uvavanyo olunokwenziwa lubandakanya:

• Uvavanyo lwegazi kunye nomchamo
• I-x-ray yesifuba
• I-ECG (i-electrocardiogram, okanye ukulandelwa kwentliziyo)

Unyango lunokubandakanya:

• Ulwelo ngomthambo (ngo-IV)
• Amayeza ukunyanga iimpawu okanye ukuguqula iziphumo libanda
• Amalahle avuselelweyo
  
• Laxative
  
• Ukuphefumla inkxaso, kubandakanya ityhubhu engena emlonyeni ukuya emiphungeni kwaye ixhunywe kumatshini wokuphefumla (i-ventilator)

Ukubuyela kwimeko yesiqhelo kunokwenzeka ukuba umntu uyaphila kwiiyure ezingama-24 zokuqala. Iingxaki ezinje nge-pneumonia, ukonakala kwemisipha ngokulala kwindawo enzima ixesha elide, okanye ukonakala kwengqondo ngokuswela ioksijini kunokubangela ukukhubazeka okusisigxina.

Bambalwa abantu abafayo ngenxa ye-antihistamine overdose. Nangona kunjalo, ukuphazamiseka kwentliziyo enzulu kunokubakho, okunokubangela ukufa.

Gcina onke amayeza kwiibhotile ezingqina ukuba abantwana abakwazi ukufikelela kuwo.

IDramamine; IiDimetabs

UAronons JK. Iziyobisi zeAnticholinergic. Ku: Aronson JK, ed. Iziphumo ebezingalindelekanga zikaMeyler zeziyobisi. Ngomhla we-16. I-Waltham, MA: Elsevier; Ngo-2016: 534-539.

IMonte AA, iHoppe JA. I-Anticholinergics. Ku: Iindonga RM, iHockberger RS, iGausche-Hill M, ii-eds. Unyango lukaRosen oluNgxamisekileyo: iikhonsepthi kunye nokuziqhelanisa neklinikhi. Umhla we-9. IPhiladelphia, PA: Elsevier; Ngo-2018: isahluko 145.